AG
RPRX icon

Algert Global’s Royalty Pharma RPRX Stock Holding History

Algert Global’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97M Sell
88,650
-49,610
-36% -$2.58M 0.06% 533
2026
Q1 		$6.63M Buy
138,260
+28,930
+26% +$1.27M 0.1% 348
2025
Q4 		$4.22M Buy
+109,330
New +$4.17M 0.07% 499

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's RPRX Position: Q2 2026 in Review

Algert Global reduced its Royalty Pharma (RPRX) stake by 36% in Q2 2026, selling an estimated $2.58M and leaving 88,650 shares worth $4.97M. The position accounts for 0.06% of the portfolio, ranked #533.

Algert Global first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.63M in Q1 2026. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Algert Global held 88,650 shares of Royalty Pharma worth $4.97M as of Q2 2026.
  • Algert Global sold 49,610 Royalty Pharma shares in Q2 2026, an estimated $2.58M.
  • Royalty Pharma made up 0.06% of Algert Global's portfolio in Q2 2026, its #533 holding.
  • Algert Global first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • Algert Global's Royalty Pharma position peaked at $6.63M in Q1 2026.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.